Based on IHC characterisation, the molecular subtypes are: luminal A-like, luminal B-like (HER2−), luminal B-like (HER2+), HER2-enriched and triple-negative breast cancer (TNBC). Here, ERBB2 is linked to triple-negative breast carcinoma.